• Most Popular
  • Most Shared

Amicus Therapeutics sets IPO at 5 million shares

WASHINGTON
Thu May 17, 2007 6:49am EDT

Stocks

   

WASHINGTON (Reuters) - Biopharmaceutical firm Amicus Therapeutics Inc. on Thursday set its planned initial public offering at 5 million shares for an estimated $14 to $16 each.

Regulatory News  |  IPOs

Morgan Stanley, Merrill Lynch & Co., JPMorgan, Lazard Capital Markets, and Pacific Growth Equities LLC are underwriting the IPO, according to an amended filing with the U.S. Securities and Exchange Commission.

Amicus intends to list its stock on the Nasdaq under the symbol "FOLD." (FOLD.O)
Regulatory News
IPOs


More from Reuters

Photo

Wide use of U.S. airport body scanners depends on Obama

NEW YORK (Reuters) - The path toward rolling out wider use of whole-body security scanners in U.S. airports runs through the White House.

» More Top News
EDITORS' NOTE: Reuters and other foreign media are subject to Iranian restrictions on leaving the office to report, film or take pictures in Tehran. A man holds a picture of Ayatollah Ruhollah Khomeini, founder of the Islamic Republic as government supporters protest against opposition demonstrations during the holy day of Ashura, in Tehran December, 30 2009. REUTERS/Caren Firouz

What next?

Six months after a disputed election, tension in Iran shows no signs of letting up.  Full Article 

IRAN
Disgraced financier Bernard Madoff is escorted by police and photographed by the media as he departs U.S. Federal Court after a hearing in New York, January 5, 2009. REUTERS/Lucas Jackson

I beg your pardon ...

Bernie Madoff became the poster boy of crooked investment schemes this year -- but he wasn't alone. Here's a look at the 10 most notorious cases of 2009.  Full Article 

Corporate Crime